SCHEMBL978058

SCHEMBL978058

O=C1CNCCN1CCO

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.35
SCN9A Q15858 1/20 0.32
MEN1 O00255 1/20 0.31
USP19 O94966 1/20 0.31
F10 P00742 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3999990 0.98 KMT2A (0.34) KMT2ASCN9AMEN1USP19
SCHEMBL4028081 0.89 KMT2A (0.33) KMT2ASCN9AMEN1USP19F10
SCHEMBL5337457 0.87 JAK2 (0.34) USP19F10
SCHEMBL8486724 0.83
SCHEMBL1176767 0.80 ALDH1A1 (0.30) SCN9A
SCHEMBL4340726 0.80 ALOX15 (0.31) F10
SCHEMBL7359626 0.80
SCHEMBL12629399 0.80
SCHEMBL3340135 0.80 F10 (0.30) F10
SCHEMBL1583740 0.80 MEN1 (0.35) KMT2AMEN1USP19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115646137-B Organic amine desulfurizing agent capable of effectively reducing foaming problem 北京北大先锋科技股份有限公司 2026-05-12 CN claimed
US-20250361181-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER HSUSTAINABILITY GMBH (DE) 2025-11-27 US claimed
EP-4565543-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER Heidelberg Materials AG (DE) 2025-06-11 EP claimed
EP-4429635-A1 SELF-EMULSIFYING OIL-IN-WATER MICROEMULSION OR NANOEMULSION, AND EMULSIFYING COMPOSITION URSAPHARM Arzneimittel GmbH (DE) 2024-09-18 EP claimed
WO-2024028219-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER HEIDELBERG MATERIALS AG (DE) 2024-02-08 WO claimed
EP-4317103-A1 DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER Heidelberg Materials AG (DE) 2024-02-07 EP claimed
EP-4225935-A1 EXTRACTION SOLUTION FOR PREPARING A BIOLOGICAL SAMPLE FOR AMPLIFICATION BASED PATHOGEN DETECTION QIAGEN GmbH (DE) 2023-08-16 EP claimed
WO-2023084038-A1 SELF-EMULSIFYING OIL-IN-WATER MICROEMULSION OR NANOEMULSION, AND EMULSIFYING COMPOSITION URSAPHARM ARZNEIMITTEL GMBH (DE) 2023-05-19 WO claimed
CN-115646137-A Organic amine desulfurizer capable of effectively reducing foaming problem 北京北大先锋科技股份有限公司 2023-01-31 CN claimed
WO-2022074087-A1 EXTRACTION SOLUTION FOR PREPARING A BIOLOGICAL SAMPLE FOR AMPLIFICATION BASED PATHOGEN DETECTION QIAGEN GMBH (DE) 2022-04-14 WO claimed
US-20090305065-A1 Composition for coloring ceramic articles VIGNALI GRAZIANO 2009-12-10 US claimed
EP-2046698-A2 COMPOSITION FOR COLORING CERAMIC ARTICLES Vignali, Graziano (IT) 2009-04-15 EP claimed
WO-2008000716-A2 COMPOSITION FOR COLORING CERAMIC ARTICLES VIGNALI GRAZIANO (IT) 2008-01-03 WO claimed
US-4514567-A Process for preparing triethylenediamine AIR PRODUCTS AND CHEMICALS, INC. (US) 1985-04-30 US claimed
CN-115646137-B Organic amine desulfurizing agent capable of effectively reducing foaming problem 北京北大先锋科技股份有限公司 2026-05-12 CN disclosed
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 US disclosed
US-12509454-B2 Thiadiazolyl derivatives IDEAYA BIOSCIENCES, INC. (US) 2025-12-30 US disclosed
US-4615826-A NONDESTRUCTIVE TO FLUOROCARBON SEALS CHEVRON RESEARCH COMPANY (US) 1986-10-07 US disclosed
US-4379064-A Oxidative passivation of polyamine-dispersants STANDARD OIL COMPANY (INDIANA) (US) 1983-04-05 US disclosed
EP-0061329-A2 Process for improving the compatibility of a polyamine dispersant with fluorocarbons by reaction with an oxidising agent AMOCO CORPORATION (US) 1982-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 KMT2A 2910/4885SCN9A 2258/4885MEN1 4795/4885
US-20090305065-A1 Composition for coloring ceramic articles CAD, SF3B5, FYN KMT2A 210/4885SCN9A 2255/4885MEN1 1423/4885
US-12509454-B2 Thiadiazolyl derivatives POLD1, POLQ, DNA2 KMT2A 2518/4885SCN9A 722/4885MEN1 3388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.